Rebecca Wissner

Title: Innovations by Rebecca Wissner in Organ Specific Protein Delivery

Introduction

Inventor Rebecca Wissner, based in Wayne, PA, has made significant contributions to the field of biomedical science with her innovative work on organelle-specific protein delivery systems. With two patents to her name, Wissner's research focuses on providing effective treatments for genetic disorders associated with non-nuclear organelles.

Latest Patents

Rebecca Wissner is known for her latest invention, which involves a fusion protein for treating non-nuclear organelle-associated disorders, such as Friedrich's Ataxia. The disclosed fusion protein is designed to deliver a protein of interest to a non-nuclear organelle effectively. It includes an organelle targeting sequence (OTS), a cell-penetrating peptide (CPP), and a target-enhancing sequence (TES). The CPP is crucial for facilitating delivery, while the TES safeguards against interference caused by the CPP. This groundbreaking work also outlines methods for administering the fusion protein to individuals in need of such treatments.

Career Highlights

Wissner’s career has been marked by her dedicated work at Larimar Therapeutics, Inc., where she applies her expertise in biochemical research towards innovative therapeutic solutions. Her contributions reflect a deep understanding of protein biology and targeted drug delivery mechanisms, showcasing her commitment to improving patient outcomes.

Collaborations

At Larimar Therapeutics, she collaborates closely with her coworker, Joan David Betton, a fellow scientist dedicated to advancing their research initiatives. The partnership between Wissner and Betton highlights the importance of teamwork in driving forward inventions that can potentially transform medical treatments.

Conclusion

Rebecca Wissner’s work exemplifies innovation in the field of biotechnology, particularly through her patents in organelle-specific protein delivery. As she continues to work at Larimar Therapeutics, her contributions have the potential to influence therapeutic strategies for genetic disorders, bringing hope to countless patients in need.